Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance.

Area of Science:

• Immunology
• Cancer Biology
• Cellular Metabolism

Background:

• Natural killer (NK) cells are critical for identifying and eliminating cancerous cells.
• Tumor microenvironments can suppress immune responses, leading to cancer progression.
• Mitochondrial function is essential for immune cell activity and survival.

Purpose of the Study:

• To investigate the role of mitochondria in the function of tumor-infiltrating NK cells in liver cancer.
• To elucidate the mechanisms behind NK cell dysfunction within the tumor microenvironment.
• To identify potential therapeutic targets for enhancing NK cell-mediated anti-tumor immunity.

Main Methods:

• Comparative analysis of mitochondria in tumor-infiltrating NK cells versus non-tumor NK cells from liver cancer patients.
• Assessment of NK cell cytotoxicity and correlation with mitochondrial morphology.
• Investigation of the mechanistic target of rapamycin-GTPase dynamin-related protein 1 (mTOR-Drp1) pathway in response to tumor hypoxia.
• Evaluation of therapeutic interventions targeting mitochondrial fragmentation.

Main Results:

• Tumor-infiltrating NK cells displayed small, fragmented mitochondria, unlike normal, tubular mitochondria in non-tumor and peripheral NK cells.
• Mitochondrial fragmentation in NK cells correlated with reduced cytotoxicity, NK cell loss, and poor patient survival.
• Hypoxia-induced mTOR-Drp1 activation in NK cells drove excessive mitochondrial fission.
• Inhibition of mitochondrial fragmentation restored NK cell metabolism, survival, and anti-tumor capacity.

Conclusions:

• Mitochondrial fragmentation is a key mechanism of immune escape in liver cancer, driven by the tumor microenvironment.
• Targeting mitochondrial dynamics in NK cells presents a promising strategy to overcome immune suppression.
• Restoring NK cell mitochondrial health can enhance their anti-tumor efficacy and improve cancer treatment outcomes.